Quantitative survey of multiple CpGs from 5 genes identifies CpG methylation panel discriminating between high- and low-grade cervical intraepithelial neoplasia

Abstract

BackgroundStudies of methylation biomarkers for cervical cancer often involved only few randomly selected CpGs per candidate gene analyzed by methylation-specific PCR-based methods, with often inconsistent results from different laboratories. We evaluated the role of different CpGs from multiple genes as methylation biomarkers for high-grade cervical intraepithelial neoplasia (CIN).ResultsWe applied a mass spectrometry-based platform to survey the quantitative methylation levels of 34 CpG units from SOX1, PAX1, NKX6-1, LMX1A, and ONECUT1 genes in 100 cervical formalin-fixed paraffin-embedded (FFPE) tissues. We then used nonparametric statistics and Random Forest algorithm to rank significant CpG methylations and support vector machine with 10-fold cross validation and 200 times bootstrap resampling to build a predictive model separating CIN II/III from CIN I/normal subjects. We found only select CpG units showed significant differences in methylation between CIN II/III and CIN I/normal groups, while mean methylation levels per gene were similar between the two groups for each gene except PAX1. An optimal classification model involving five CpG units from SOX1, PAX1, NKX6-1, and LMX1A achieved 81.2% specificity, 80.4% sensitivity, and 80.8% accuracy.ConclusionsOur study suggested that during CIN development, the methylation of CpGs within CpG islands is not uniform, with varying degrees of significance as biomarkers. Our study emphasizes the importance of not only methylated marker genes but also specific CpGs for identifying high-grade CINs. The 5-CpG classification model provides a promising biomarker panel for the early detection of cervical cancer.Electronic supplementary materialThe online version of this article (doi:10.1186/s13148-014-0037-1) contains supplementary material, which is available to authorized users.

Noninvasive diagnosis of urothelial cancer in urine using DNA hypermethylation signatures—Gender matters

“…When using LASSO for parameter shrinkage, we aimed to create a more stable model by restricting the number of model coefficients and feature selections and reducing unwanted effects due to overfitting . In line with previous studies, the combination of individual CpGs appeared to improve the diagnostic reliability for UCa. However, the calculated sets were dependent on the type of control group, and only one CpG (35 CpG 7) was part of the LASSO‐derived CpG sets that could distinguish between both UCa and UCt, and UCa and PCt.…”

5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene

“…In cancer, hypermethylation of CpG islands, regarded as regions of DNA 0.5-4 kb with C+G content >0.5 (31)(32)(33), contributes to transcription silencing of tumor-suppressor genes. There is mounting evidence that abnormal hypermethylation of the promoter is the mechanism involved in the silencing of tumor-suppressor genes in tumorigenesis.…”